These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 17022153)

  • 21. Enhancement of bioavailability by lowering of fat content in topical formulations.
    Wirén K; Frithiof H; Sjöqvist C; Lodén M
    Br J Dermatol; 2009 Mar; 160(3):552-6. PubMed ID: 19120336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An alkylpolyglucoside surfactant as a prospective pharmaceutical excipient for topical formulations: the influence of oil polarity on the colloidal structure and hydrocortisone in vitro/in vivo permeation.
    Savić S; Savić M; Tamburić S; Vuleta G; Vesić S; Müller-Goymann CC
    Eur J Pharm Sci; 2007 Apr; 30(5):441-50. PubMed ID: 17331708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rheological properties of three different vitamin D ointments and their clinical perception by patients with mild to moderate psoriasis.
    Marty JP; Lafforgue C; Grossiord JL; Soto P
    J Eur Acad Dermatol Venereol; 2005 Nov; 19 Suppl 3():7-10. PubMed ID: 16274405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted delivery of salicylic acid from acne treatment products into and through skin: role of solution and ingredient properties and relationships to irritation.
    Rhein L; Chaudhuri B; Jivani N; Fares H; Davis A
    J Cosmet Sci; 2004; 55(1):65-80. PubMed ID: 15037921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The "bubble point" for validation of drug release or simulated absorption tests for ointments.
    Realdon N; Tagliaboschi A; Perin F; Ragazzi E
    Pharmazie; 2005 Dec; 60(12):910-6. PubMed ID: 16398267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Percutaneous absorption.
    Brisson P
    Can Med Assoc J; 1974 May; 110(10):1182-5. PubMed ID: 4597976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Equilibrium solubilization of lipophilic therapeutic agents by aqueous solutions of products of catalytic oxyethylation of Croda-type lanolin as model excipients of the class of non-ionic surface active agents.
    Zgoda MM; Lukosek M; Nachajski MJ
    Polim Med; 2007; 37(2):33-50. PubMed ID: 17957947
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of formulation on the in vitro transdermal penetration of flutrimazole.
    Ramis J; Conte L; Segado X; Forn J; Lauroba J; Calpena A; Escribano E; Domenech J
    Arzneimittelforschung; 1997 Oct; 47(10):1139-44. PubMed ID: 9368709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucoadhesion, hydration and rheological properties of non-aqueous delivery systems (NADS) for the oral cavity.
    Zaman MA; Martin GP; Rees GD
    J Dent; 2008 May; 36(5):351-9. PubMed ID: 18343013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lyotropic liquid crystal preconcentrates for the treatment of periodontal disease.
    Fehér A; Urbán E; Eros I; Szabó-Révész P; Csányi E
    Int J Pharm; 2008 Jun; 358(1-2):23-6. PubMed ID: 18403142
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of an eucalyptus oil containing topical drug delivery system for selected steroid hormones.
    Biruss B; Kählig H; Valenta C
    Int J Pharm; 2007 Jan; 328(2):142-51. PubMed ID: 16950579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermal targeting of tacrolimus using colloidal carrier systems.
    Goebel AS; Neubert RH; Wohlrab J
    Int J Pharm; 2011 Feb; 404(1-2):159-68. PubMed ID: 21094231
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of various vehicles on the penetration of flufenamic acid into human skin.
    Wagner H; Kostka KH; Adelhardt W; Schaefer UF
    Eur J Pharm Biopharm; 2004 Jul; 58(1):121-9. PubMed ID: 15207545
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical delivery of lipophilic drugs from o/w Pickering emulsions.
    Frelichowska J; Bolzinger MA; Pelletier J; Valour JP; Chevalier Y
    Int J Pharm; 2009 Apr; 371(1-2):56-63. PubMed ID: 19135516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Release characteristics of anionic drug compounds from liquid crystalline gels. Part II. The effects of ion pairing and buffering on the passive delivery of anionic drugs across non-rate-limiting membranes.
    Fitzpatrick D; Corish J
    Int J Pharm; 2006 Mar; 311(1-2):139-46. PubMed ID: 16426777
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Penetration of hydrocortisone into excised human skin under the influence of cyclodextrins.
    Preiss A; Mehnert W; Frömming KH
    Pharmazie; 1995 Feb; 50(2):121-6. PubMed ID: 7700965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A stability indicating assay for a combination of morphine sulphate with levomepromazine hydrochloride used in palliative care.
    Al-Tannak NF; Cable CG; McArthur DA; Watson DG
    J Clin Pharm Ther; 2012 Feb; 37(1):71-3. PubMed ID: 21410738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [In vitro comparison of transdermal characteristics of xiaoyu ointment and xiaoyu plaster].
    Zhu C; Peng L; Chen B; He Q; Wen Q
    Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(12):1599-602. PubMed ID: 22007541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal delivery of hydrophobic and hydrophilic local anesthetics from o/w and w/o Brij 97-based microemulsions.
    Junyaprasert VB; Boonme P; Songkro S; Krauel K; Rades T
    J Pharm Pharm Sci; 2007; 10(3):288-98. PubMed ID: 17727792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancement of transdermal delivery of theophylline using microemulsion vehicle.
    Zhao X; Liu JP; Zhang X; Li Y
    Int J Pharm; 2006 Dec; 327(1-2):58-64. PubMed ID: 16926077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.